Bioceres Crop Solutions Corp. BIOX

Healthcare SIC 2870 - Agricultural Chemicals NAICS Manufacturing › Chemical Manufacturing › Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing › Fertilizer and Compost Manufacturing derived Nasdaq

Last close —
Market cap —
52-week range — - —

No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.

Valuation FY2025 figures against the last close

P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS—

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $335.1M$464.8M$420.1M$334.8M$209.5M$173.1M$160.6M$133.5M—$41.2M
Operating income -$2.2M$45.9M$54.2M$39.9M$38.4M$39.1M$32.1M$15.7M—$207.0K
Net income -$58.8M$7.3M$20.2M-$3.9M-$3.8M$4.2M-$16.4M-$14.3M—-$6.2M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets $763.6M$852.5M$818.1M$518.2M$394.6M$297.6M$242.5M$196.6M$239.9M—
Total equity $295.2M$351.4M$330.5M$158.3M$90.3M$60.7M$62.1M$33.1M$77.2M$83.7M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001104659-25-108999.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -200M 0 200M 400M 600M Revenue, FY2016: 41.2M Net income, FY2016: -6.2M Revenue, FY2018: 133.5M Net income, FY2018: -14.3M Revenue, FY2019: 160.6M Net income, FY2019: -16.4M Revenue, FY2020: 173.1M Net income, FY2020: 4.2M Revenue, FY2021: 209.5M Net income, FY2021: -3.8M Revenue, FY2022: 334.8M Net income, FY2022: -3.9M Revenue, FY2023: 420.1M Net income, FY2023: 20.2M Revenue, FY2024: 464.8M Net income, FY2024: 7.3M Revenue, FY2025: 335.1M Net income, FY2025: -58.8M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $41.2M — $133.5M $160.6M $173.1M $209.5M $334.8M $420.1M $464.8M $335.1M
Gross profit — — — — — — — — — —
Net income -$6.2M — -$14.3M -$16.4M $4.2M -$3.8M -$3.9M $20.2M $7.3M -$58.8M

Others in SIC 2870

TickerCompanyMarket capP/ERevenue growth
CF CF Industries Holdings, Inc. $18.26B 13.5x 19.3%
MOS MOSAIC CO $5.67B 10.5x 8.4%
SMG SCOTTS MIRACLE-GRO CO $3.45B 24.0x -3.9%
UAN CVR PARTNERS, LP $1.33B 13.4x 15.4%
CBUS Cibus, Inc. $108.2M — -14.6%
AVD AMERICAN VANGUARD CORP $30.4M — -5.9%
SNES SenesTech, Inc. $4.6M — 19.6%
NTR Nutrien Ltd. — — —